Last reviewed · How we verify
Bupivacaine FNB — Competitive Intelligence Brief
marketed
Local anesthetic
Voltage-gated sodium channels
Pain Management / Regional Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Bupivacaine FNB (Bupivacaine FNB) — Pacira Pharmaceuticals, Inc. Bupivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and conduction of nerve impulses.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bupivacaine FNB TARGET | Bupivacaine FNB | Pacira Pharmaceuticals, Inc | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Liposome bupivacaine | Liposome bupivacaine | Catherine Vandepitte, M.D. | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| IV lignocaine bolus and infusion | IV lignocaine bolus and infusion | University of Auckland, New Zealand | marketed | Local anesthetic; Class IB antiarrhythmic agent | Voltage-gated sodium channels | |
| Intravenous Lidocaine infusion + Standard Anesthesia | Intravenous Lidocaine infusion + Standard Anesthesia | Instituto Mexicano del Seguro Social | marketed | Local anesthetic (sodium channel blocker) | Voltage-gated sodium channels | |
| Infiltration - EXPAREL | Infiltration - EXPAREL | Pacira Pharmaceuticals, Inc | marketed | Long-acting local anesthetic | Voltage-gated sodium channels | |
| Anesthetics, Local | Anesthetics, Local | University of Alberta | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Levobupivacaine and Fentanyl | Levobupivacaine and Fentanyl | Hamad Medical Corporation | marketed | Local anesthetic with opioid analgesic combination | Voltage-gated sodium channels; mu-opioid receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic class)
- University of California, San Diego · 3 drugs in this class
- Durect · 3 drugs in this class
- Pacira Pharmaceuticals, Inc · 3 drugs in this class
- Wake Forest University Health Sciences · 3 drugs in this class
- Medical University of Vienna · 3 drugs in this class
- Imperial College London · 2 drugs in this class
- Hvidovre University Hospital · 2 drugs in this class
- Innocoll · 2 drugs in this class
- George Washington University · 2 drugs in this class
- Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bupivacaine FNB CI watch — RSS
- Bupivacaine FNB CI watch — Atom
- Bupivacaine FNB CI watch — JSON
- Bupivacaine FNB alone — RSS
- Whole Local anesthetic class — RSS
Cite this brief
Drug Landscape (2026). Bupivacaine FNB — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-fnb. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab